MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock
MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock (STRF) Financial Performance & Income Statement Overview
Explore the financials of MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock (STRF), including yearly and quarterly data on income, cash flow, and balance sheets.
MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock (STRF) Income Statement & Financial Overview
Explore comprehensive income reports for MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock STRF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $111.07M | $120.70M | $116.07M | $111.44M |
| Cost of Revenue | $33.97M | $34.17M | $34.35M | $30.93M |
| Gross Profit | $77.09M | $86.53M | $81.72M | $80.51M |
| Gross Profit Ratio | $0.69 | $0.72 | $0.70 | $0.72 |
| R&D Expenses | $24.42M | $25.69M | $33.30M | $30.31M |
| SG&A Expenses | $68.08M | $71.20M | $68.92M | $70.38M |
| Operating Expenses | $6.00B | $1.10B | $514.30M | $280.78M |
| Total Costs & Expenses | $6.03B | $1.14B | $548.65M | $311.72M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $17.11M | $16.46M | $18.13M | $15.47M |
| Depreciation & Amortization | $38.15M | $5.13M | $5.98M | $3.65M |
| EBITDA | -$5.92B | -$1.003B | -$454.57M | -$195.93M |
| EBITDA Ratio | -$53.31 | -$8.31 | -$3.92 | -$1.76 |
| Operating Income | -$5.92B | -$1.02B | -$432.58M | -$200.27M |
| Operating Income Ratio | -$53.31 | -$8.42 | -$3.73 | -$1.80 |
| Other Income/Expenses (Net) | -$21.04M | -$10.31M | -$46.10M | -$14.77M |
| Income Before Tax | -$5.94B | -$1.03B | -$478.68M | -$215.05M |
| Income Before Tax Ratio | -$53.50 | -$8.51 | -$4.12 | -$1.93 |
| Income Tax Expense | -$1.73B | -$355.93M | -$138.50M | -$112.49M |
| Net Income | -$4.23B | -$670.81M | -$340.17M | -$102.56M |
| Net Income Ratio | -$38.07 | -$5.56 | -$2.93 | -$0.92 |
| EPS | -$16.49 | -$3.03 | -$1.72 | -$0.57 |
| Diluted EPS | -$16.49 | -$3.03 | -$1.72 | -$0.57 |
| Weighted Avg Shares Outstanding | $256.47M | $221.61M | $197.27M | $178.61M |
| Weighted Avg Shares Outstanding (Diluted) | $256.47M | $221.61M | $197.27M | $178.61M |
The company's financials show resilient growth, with revenue advancing from $111.44M in Q2 2024 to $111.07M in Q1 2025. Gross profit remained healthy with margins at 69% in Q1 2025 compared to 72% in Q2 2024. Operating income hit -$5.92B last quarter, sustaining a consistent -5331% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$5.92B. Net income dropped to -$4.23B, while earnings per share reached -$16.49. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan